Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index, and 1 are not checked yet.

Deep learning in cancer pathology: a new generation of clinical biomarkers

Open access

Abstract

Clinical workflows in oncology rely on predictive and prognostic molecular biomarkers. However, the growing number of these complex biomarkers tends to increase the cost and time for decision-making in routine daily oncology practice; furthermore, biomarkers often require tumour tissue on top of routine diagnostic material. Nevertheless, routinely available tumour tissue contains an abundance of clinically relevant information that is currently not fully exploited. Advances in deep learning (DL), an artificial intelligence (AI) technology, have enabled the extraction of previously hidden information directly from routine histology images of cancer, providing potentially clinically useful information. Here, we outline emerging concepts of how DL can extract biomarkers directly from histology images and summarise studies of basic and advanced image analysis for cancer histology. Basic image analysis tasks include detection, grading and subtyping of tumour tissue in histology images; they are aimed at automating pathology workflows and consequently do not immediately translate into clinical decisions. Exceeding such basic approaches, DL has also been used for advanced image analysis tasks, which have the potential of directly affecting clinical decision-making processes. These advanced approaches include inference of molecular features, prediction of survival and end-to-end prediction of therapy response. Predictions made by such DL systems could simplify and enrich clinical decision-making, but require rigorous external validation in clinical settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-020-01122-x

Cites

83 of 84 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Consensus pipeline of deep learning in pathology. a Routine histology image of lung cancer (from The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA)). b Size comparison (in terms of pixels) of a chest CT scan of the same patient. c Consensus image-processing pipeline. First, either the whole slide or just the tumour region is tessellated into smaller image tiles. d These tiles comprise an image library, similar to the library preparation (prep.) in genome sequencing. e Tiles are preprocessed to achieve rotational constancy and augment the dataset. f Deep- learning classifiers are developed and deployed by splitting the patient cohort into a training and testing set, by using cross-validation or by having multiple cohorts available for training and testing. g Ideally, an additional external dataset is used for validation of the resulting classifier.
Fig. 1 Consensus pipeline of deep learning in pathology. a Routine histology image of lung cancer (from The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA)). b Size comparison (in terms of pixels) of a chest CT scan of the same patient. c Consensus image-processing pipeline. First, either the whole slide or just the tumour region is tessellated into smaller image tiles. d These tiles comprise an image library, similar to the library preparation (prep.) in genome sequencing. e Tiles are preprocessed to achieve rotational constancy and augment the dataset. f Deep- learning classifiers are developed and deployed by splitting the patient cohort into a training and testing set, by using cross-validation or by having multiple cohorts available for training and testing. g Ideally, an additional external dataset is used for validation of the resulting classifier.CC BY · PubMed Central
Fig. 2 Clinical applications of basic and advanced deep-learning (DL) image analysis in histopathology. DL pathology can be applied to tumour detection and identification of subtype (basic applications) or to predict clinical features of interest (advanced application). Published studies (indicated by reference number) are classified according to the level of evidence (monocentric (internally approved), multicentric (externally approved) or FDA approved). a Basic image analysis tasks, including tumour detection, grading and subtyping. b Advanced image analysis tasks, including those that exceed pathologists’ routine capacities, such as prediction of mutation, prognosis and response. AI artificial intelligence, NSCLC non-small-cell lung cancer, WSI whole-slide image, ER oestrogen receptor, MSI microsatellite instability, GI gastrointestinal, SPOP speckle-type BTB/POZ protein, BAP1 BRCA-associated protein 1, HNSCC head and neck squamous cell carcinoma, CCA cholangiocarcinoma.
Fig. 2 Clinical applications of basic and advanced deep-learning (DL) image analysis in histopathology. DL pathology can be applied to tumour detection and identification of subtype (basic applications) or to predict clinical features of interest (advanced application). Published studies (indicated by reference number) are classified according to the level of evidence (monocentric (internally approved), multicentric (externally approved) or FDA approved). a Basic image analysis tasks, including tumour detection, grading and subtyping. b Advanced image analysis tasks, including those that exceed pathologists’ routine capacities, such as prediction of mutation, prognosis and response. AI artificial intelligence, NSCLC non-small-cell lung cancer, WSI whole-slide image, ER oestrogen receptor, MSI microsatellite instability, GI gastrointestinal, SPOP speckle-type BTB/POZ protein, BAP1 BRCA-associated protein 1, HNSCC head and neck squamous cell carcinoma, CCA cholangiocarcinoma.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Research works printed but not linked: 1

  1. Noorbakhsh, J., Farahmand, S. & Soltanieh-ha, M. Pan-cancer classifications of tumor histological images using deep learning. Preprint at https://www.biorxiv.org/content/10.1101/715656v1 (2019). · doi:10.1101/715656v1

Cited by

See all 710

Metadata

Authors
Echle, A., Rindtorff, N. T., Brinker, T. J., Luedde, T., Pearson, A. T., & Kather, J. N.
Affiliations
  • Universitätsklinikum Aachen (DE)
  • German Cancer Research Center (DE)
  • Düsseldorf University Hospital (DE)
  • University of Chicago (US)
Corresponding author
Kather, Jakob Nikolas
Venue
British Journal of Cancer
Published
2020-11-18
Volume
124
Issue
4
Pages
686-696
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W3104135675
Cited by
667
References
85
Citations by year
2026: 125 · 2025: 125 · 2024: 142 · 2023: 117 · 2022: 108 · 2021: 50
FWCI
2.36
Type
journal article
Language
en
Open access
Licence
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion, cc-by)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
  • RWTH Publications (RWTH Aachen)
Funders
  • Deutsche Forschungsgemeinschaft (LU 1360/3-1, SFB CRC1382/P01, SFB TRR 57, P06)
  • Deutsche Krebshilfe (#70113864)
  • RWTH Aachen University (691906)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
deep learning, cancer pathology, clinical biomarkers, histological image analysis, cancer detection, tumour grading, cancer subtyping, survival prediction, treatment response prediction, external validation, clinical decision-making
MeSH terms
Deep Learning, Decision Making, Humans, Image Processing, Computer-Assisted, Neoplasms, Prognosis, Biomarkers, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep learning in cancer pathology: a new generation of clinical biomarkers. https://app.cochat.ai/papers/10.1038/s41416-020-01122-x
The paper
Echle, A., Rindtorff, N. T., Brinker, T. J., Luedde, T., Pearson, A. T., & Kather, J. N. (2021). Deep learning in cancer pathology: a new generation of clinical biomarkers. British Journal of Cancer. https://doi.org/10.1038/s41416-020-01122-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.